Valerie Odegard

Insider Reports History

Entity
Individual
Location
C/O Silverback Therapeutics, Inc., 500 Fairview Avenue N, Suite 600, Seattle, WA
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Valerie Odegard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silverback Therapeutics, Inc. President and CSO Common Stock 61.6K $233K $3.78 May 2, 2022 Direct
Silverback Therapeutics, Inc. President and CSO Stock Option (right to buy) 90.5K May 2, 2022 Direct

Insider Reports Filed by Valerie Odegard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY Silverback Therapeutics, Inc. May 2, 2022 2 $0 4 May 4, 2022 President and CSO
SPRY Silverback Therapeutics, Inc. Feb 1, 2022 3 $0 4 Feb 2, 2022 President and CSO